Evaxion A/S (EVAX)
NASDAQ: EVAX · Real-Time Price · USD
3.010
-0.140 (-4.44%)
At close: Aug 28, 2026, 4:00 PM EDT
2.980
-0.030 (-1.00%)
After-hours: Aug 28, 2026, 6:56 PM EDT
Evaxion Market Cap
Evaxion has a market cap or net worth of $25.1 million as of August 28, 2026. Its market cap has increased by 31.17% in one year.
Market Cap
25.10M
Enterprise Value
18.21M
1-Year Change
31.17%
Ranking
Category
Stock Price
$3.01
ChartMarket Cap Chart
Since the IPO on February 5, 2021, Evaxion's market cap has decreased from $191.99M to $25.10M, a decrease of -86.92%. That is a compound annual growth rate of -30.64%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 25.10M | -36.90% |
| Dec 31, 2025 | 39.78M | 702.21% |
| Dec 31, 2024 | 4.96M | -80.92% |
| Dec 29, 2023 | 25.99M | -39.34% |
| Dec 30, 2022 | 42.84M | -58.12% |
| Dec 31, 2021 | 102.29M | -46.72% |
| Feb 5, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| GridAI Technologies | 28.40M |
| CEL-SCI | 28.14M |
| NextCure | 27.62M |
| Lantern Pharma | 27.61M |
| Atossa Therapeutics | 26.35M |
| BeyondSpring | 26.32M |
| Enlivex | 25.79M |
| Quantum BioPharma | 25.04M |